Figure 2.
ORRs. Includes all enrolled patients and subgroups based on bortezomib-refractory status and number of prior lines of therapy received. One patient’s information regarding bortezomib-refractory status was missing.
ORRs. Includes all enrolled patients and subgroups based on bortezomib-refractory status and number of prior lines of therapy received. One patient’s information regarding bortezomib-refractory status was missing.
